生物性资产价值变动影响利润，静待2024逐步恢复

昭衍新药（603127.SH）/医药生物 证券研究报告/公司点评 2024 年 04 月 07 日 | --- | --- | --- | --- | --- | --- | --- | --- | |-----------------------------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ...